Emi Ishikawa

1PUBLICATIONS
9CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jan 13, 2023
Population Pharmacokinetics, Pharmacogenomics, and Adverse Events of Osimertinib and its Two Active Metabolites, AZ5104 and AZ7550, in Japanese Patients with Advanced Non-small Cell Lung Cancer: a Prospective Observational Study.

Emi Ishikawa, Yuta Yokoyama, Haruna Chishima

Pageof 1

Frequent Collaborators

1 joint publications

Yuta Yokoyama

1 joint publications

Hidefumi Kasai

1 joint publications

Shinnosuke Ikemura

1 joint publications

Ichiro Kawada